LakeShore Biopharma Co., Ltd. (LSB)
(Delayed Data from NSDQ)
$0.48 USD
+0.01 (1.60%)
Updated Jul 26, 2024 03:55 PM ET
After-Market: $0.48 0.00 (0.52%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum A VGM
Price, Consensus and EPS Surprise
LSB 0.48 +0.01(1.60%)
Will LSB be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for LSB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for LSB
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
LakeShore Biopharma Announces Executive Reshuffle
LakeShore Biopharma Reveals Major Board Changes
YS Biopharma Announces Name Change to LakeShore Biopharma
YS Biopharma Announces Results of Extraordinary General Meeting